CardioExchange Archive

September 30th, 2014

No Difference in Survival Found for Different Aortic Valve Prostheses

Larry Husten, PHD

A new study published in JAMA suggests that younger patients who need aortic valve replacement (AVR) may now be more eligible to receive bioprosthetic valves. Each year about 50,000 people in the U.S. undergo AVR surgery. Older patients generally receive bioprosthetic valves because these valves are less prone to clotting and bleeding complications. Surgeons are often […]

---

May 27th, 2014

Choosing a Prosthetic Valve: What Do You Say to Your Patient?

Harlan M. Krumholz, MD, SM

In this scenario based on prosthetic valve choice, Harlan Krumholz asks, “What do you say to your patient?”

---

January 21st, 2014

Dangerous Rapid Calcification Observed In Pediatric Patients After Aortic Valve Replacement

Larry Husten, PHD

Pediatric cardiac surgeons at Boston Children’s Hospital are warning the medical community about a potentially fatal problem in children and young adults who received a bioprosthetic valve manufactured by Sorin. The surgeons initially became concerned when a young, asymptomatic patient died suddenly after her valve underwent rapid calcification, only 7 months after a routine follow-up echocardiogram found […]

---

December 3rd, 2012

Selections from Richard Lehman’s Literature Review: December 3rd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the association between aldosterone-antagonist therapy and mortality and readmission among patients with HF and reduced EF, warfarin therapy after bioprosthetic AVR, and more.

---